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Background and purpose   In a previous study based on the Finn-
ish Arthroplasty Register, the survival of cementless stems was 
better than that of cemented stems in younger patients. However, 
the survival of cementless cups was poor due to osteolysis. In the 
present study, we analyzed population-based survival rates of the 
cemented and cementless total hip replacements in patients under 
the age of 55 years with primary osteoarthritis in Finland. 
Patients and methods   3,668 implants fulfilled our inclusion 
criteria. The previous data included years 1980–2001, whereas the 
current study includes years 1987–2006. The implants were clas-
sified in 3 groups: (1) implants with a cementless, straight, proxi-
mally circumferentially porous-coated stem and a porous-coated 
press-fit cup (cementless group 1); (2) implants with a cement-
less, anatomic, proximally circumferentially porous-coated stem, 
with or without hydroxyapatite, and a porous-coated press-fit cup 
with or without hydroxyapatite (cementless group 2); and (3) a 
cemented stem combined with a cemented all-polyethylene cup 
(the cemented group). Analyses were performed separately for 
2  time  periods:  those  operated  1987–1996  and  those  operated 
1997–2006.
Results   The 15-year survival for any reason of cementless 
total  hip  replacement  (THR)  group  1  operated  on  1987–1996 
(62%; 95% CI: 57–67) and cementless group 2 (58%; CI: 52–66) 
operated on during the same time period was worse than that of 
cemented THRs (71%; CI: 62–80), although the difference was 
not statistically significant. The revision risk for aseptic loosen-
ing of cementless stem group 1 operated on 1987–1996 (0.49; CI: 
0.32–0.74) was lower than that for aseptic loosening of cemented 
stems (p = 0.001). 
Interpretation      Excessive  wear  of  the  polyethylene  liner 
resulted in numerous revisions of modular cementless cups. The 
outcomes of total hip arthroplasty appear to have been relatively 
unsatisfactory for younger patients in Finland.

Only a few register-based studies have yielded results of THA 
for primary osteoarthritis in younger patients at a population-
based level (Havelin et al. 2000, Malchau et al. 2002, Eske-
linen et al. 2005, 2006). In patients under the age of 55 years, 
data from population-based studies have suggested that the 
survival of cementless, proximally porous-coated stems can 
be as good as that of cemented stems (Havelin et al. 2000, 
Eskelinen et al. 2005). However, it has not been clear whether 
cementless cups perform as well as cemented cups in younger 
patients. 
On the basis of the Finnish Arthroplasty Register, we evalu-
ated population-based data on the survival of primary total hip 
replacements performed for primary osteoarthritis in patients 
under the age of 55 years. The data including years 1980–2001 
has been published earlier (Eskelinen et al. 2005), whereas the 
current study includes data from 1987 to 2006.
Patients and methods
Since 1980, data on total hip replacements have been collected 
by the Finnish Arthroplasty Register (Paavolainen et al. 1991, 
Puolakka et al. 2001). Healthcare authorities, institutions, and 
orthopedic units in Finland are obliged to provide the National 
Agency for Medicines with information that is essential for 
monitoring past and current trends for the efficacious use of 
materials, approaches, and designs used in orthopedic medi-
cine. The coverage in the Finnish Arthroplasty Register was 
initially analyzed for the period from 1994 to 1995 by com-
paring its data with those of the discharge registers of partici-
pating hospitals. 90% of all implantations actually performed 
were reported to the register (Puolakka et al. 2001). Since 
1995, the data in the register have been compared with those 
in hospital discharge registers every few years. Currently, 98% 522  Acta Orthopaedica 2011; 82 (5): 521–529
of implantations are recorded in the Finnish Arthroplasty Reg-
ister (Peltola 2009).
Inclusion and exclusion criteria
Only patients under the age of 55 years at the time of the 
primary operation were included. In order to eliminate the 
effect of diagnosis as a confounding factor, only patients with 
primary osteoarthritis as a recorded indication for operation 
were included. Only total hip replacements (cup and stem 
combinations) that had been used in more than 10 operations 
during the study period were included in the present study 
(Havelin et al. 1995a, b). Prosthetic components with well-
documented poor results, e.g. cementless, smooth-threaded 
cups (Engh et al. 1990, Tallroth et al. 1993, Simank et al. 
1997, Eskelinen et al. 2005), and implants that did not fit into 
any of the groups of interest (see below) were excluded. The 
data of cement brands used have been included in the Finn-
ish Register from 1996 onward. We excluded cement brands 
with known poor results, such as Boneloc and CMW, from 
the study.
Implant group analysis
The success rate of different implant groups was analyzed. 
All hip replacements included were classified into the fol-
lowing groups: (1) a cementless, straight, proximally circum-
ferentially porous-coated stem with a porous-coated press-fit 
cup (cementless group 1); (2) a cementless, anatomic, proxi-
mally  circumferentially  porous-coated  stem  with  or  with-
out hydroxyapatite, and a porous-coated press-fit cup with 
or without hydroxyapatite (cementless group 2); and (3) a 
cemented total hip replacement (a cemented stem combined 
with a cemented all-polyethylene cup).
Femoral components of the total hip replacements included 
were  separately  classified  into  3  stem  groups:  (1)  cement-
less, straight, proximally circumferentially porous-coated; (2) 
cementless, anatomic, proximally circumferentially porous-
coated with or without hydroxyapatite (fit and fill); and (3) 
cemented. 
Acetabular  components  of  the  total  hip  replacements 
included were also separately classified into 3 cup groups: (1) 
cementless, press-fit porous-coated; (2) cementless, hydroxy-
apatite-coated; and (3) cemented all-polyethylene.
Study population
During the whole study period (1987–2006), 97,164 primary 
THRs were performed in Finland. Of these operations, 13,115 
(13%) were performed on patients under the age of 55 years. 
Primary osteoarthritis was an indication in 50% (n = 6,578) of 
these operations. After exclusion of implants according to our 
study criteria, 3,668 total hip replacements were included in 
the final analysis (Table 1).
Primary operations
During the study period, 96 different stem designs were used 
in patients who were younger than 55 years old and who had 
primary osteoarthritis. Of these stem designs, 47 were used 
in fewer than 10 operations. Cementless stems were used in 
73% of the primary operations during the follow-up period. 
In patients who were less than 55 years old and had primary 
osteoarthritis, 93 different cup designs were used during the 
study period. Of these, 35 were used in fewer than 10 opera-
tions. Cementless cups were used in 90% of the primary oper-
ations during the follow-up period (Table 1). 
Revision operations
Revisions  were  linked  to  the  primary  operation  using  the 
unique personal identity number assigned to each resident of 
Finland. Revision is defined as either exchange or removal 
of the cup and/or stem, or exchange of the liner. Infections 
are mainly treated with 2-stage revision in Finland. Only the 
first operation, i.e. removal of the prosthesis, is recorded as 
first revision in the Finnish Arthroplasty Register. The second 
operation, i.e. re-replacement, is recorded as a re-revision and 
was not included in the study. During the study period, 502 
revision operations were performed for patients in the study 
group (Table 2).
Table 1. Demographic data on total hip replacements analyzed in the study
Total hip replacement  Number of  Follow-up  Age   Females  Number of
group  operations  (year) a  (year) a  (%)  hospitals
1987–1996         
  Cementless group #1   767  10.9 (0–18)  48 (24–54)  45  41
  Cementless group #2   419  11.3 (0–20)  49 (27–54)  47  40
  Cemented THR  140  11.6 (0–20)  50 (19–54)  56  31
  Subtotal  1,326       
1997–2006         
  Cementless group #1   1,632  4.5 (0–10)  50 (16–54)  47  59
  Cementless group #2  534  5.2 (0–10)  50 (25–54)  48  38
  Cemented THR  176  4.9 (0–10)  51 (26–54)  54  30
  Subtotal  2,342       
Total  3,668   
a  mean (range)     Acta Orthopaedica 2011; 82 (5): 521–529 
Statistics
The  endpoint  for  survival  was  defined  as  revision  when 
either one component (including liner and femoral head) or 
the  whole  implant  was  removed  or  exchanged.  Both  revi-
sion for any reason and revision for aseptic loosening served 
separately as endpoints. Revisions for any reason included 
(in addition to revisions for aseptic loosening of the cup and/
or the stem) revisions for infection, dislocation, malposition, 
periprosthetic  fracture,  and  fracture  of  the  prosthesis,  and 
other causes (including exchange of liner). The data from the 
study  period  1987–2006  were  analyzed  in  2  separate  time 
periods, 1987–1996 and 1997–2006, to have comparable fol-
low-up periods in both study groups. Kaplan-Meier survival 
data were used to predict survival of implants at 5, 10, and 
15 years. At each follow-up time point, survival rates were 
published only for implants with more than 20 patients at risk 
(Dorey 2004). Survival data obtained by Kaplan-Meier analy-
sis were compared using the log-rank test. Patients who died 
or emigrated from Finland during the follow-up period were 
excluded at that point. The Cox multiple regression model   
was used to study differences between groups and to adjust 
for potential confounding factors. The factors studied with 
the Cox model were implant groups, age, and sex. Departures 
from the proportional hazards assumption were evaluated by 
visual inspection of the Cox curves. The follow-up period was 
divided into 2 parts to avoid crossing curves. In the current 
study, bilateral observations were included in the analysis. The 
bias introduced from neglecting bilateral prostheses is minute 
(Robertsson and Ranstam 2003).
When  stem  groups  were  analyzed  with  the  Cox  model, 
cemented stems with well-documented good long-term results 
(Havelin  et  al.  2000,  Malchau  et  al.  2002, Williams  et  al. 
2002, Callaghan et al. 2004, Buckwalter et al. 2006) served 
as the reference group. Similarly, all-polyethylene cemented 
cups (Havelin et al. 2000, Raber et al. 2001, Malchau et al. 
2002, Sanchez-Sotelo et al. 2002, Williams et al. 2002, Cal-
laghan et al. 2004, Della Valle et al. 2004, Buckwalter et al. 
2006) served as the reference group on the acetabular side, 
and  cemented  total  hip  replacements  (Havelin  et  al.  2000, 
Malchau et al. 2002, Williams et al. 2002, Issack et al. 2003, 
Callaghan et al. 2004, Della Valle et al. 2004, Buckwalter et 
al. 2006) served as the reference group in analyses of total 
hip replacements. When the effects of age and sex on implant 
survival were analyzed with the Cox model, adjustment was 
also made for implant groups (Furnes et al. 2001). Cox regres-
sion analyses provided estimates of survival probabilities and 
adjusted risk ratios for revision. Estimates from Cox analy-
ses were used to construct adjusted survival curves at mean 
values of the risk factors. The Wald test was used to calculate 
p-values for data obtained from the Cox multiple regression 
analysis. Differences between groups were considered to be 
statistically significant if the p-values were less than 0.05 in a 
two-tailed test.
Table 2. Reasons for revision
  A  B  C  D  E  F  G  H  I  J  K  L
1987–1996                     
  Cementless group #1   767  35  36  3  6  14  10  12  5  92  213
  Cementless group #2   419  19  56  13  1  5  3  7  1  42  137
  Cemented THR  140  14  12  7  0  1  0  1  0  0  35
1997–2006                     
  Cementless group #1   1,632  8  7  9  9  21  11  0  8  15  88
  Cementless group #2   534  1  4  4  1  3  0  2  1  5  21
  Cemented THR  176  3  1  0  2  2  0  0  0  0  8
Total  3,668  80  116  36  19  46  24  22  15  154  502
A  Total hip replacement group 
  cementless group #1: a cementless, straight proximally porous-coated stem and a modular cementless 
press-fit porous-coated cup; 
  cementless group #2: a cementless, anatomic proximally porous and/or hydroxyapatite-coated stem and 
a modular press-fit and/or 
  hydroxyapatite-coated cup.
B  Number of operations 
C Aseptic loosening (both)  
D Aseptic loosening (cup) 
E  Aseptic loosening (stem) 
F  Infection 
G Dislocation 
H Malposition 
I  Fracture of the prosthesis 
J  Periprosthetic fracture 
H Other reasons (including, for example, liner revisions due to excessive wear.) 
L  Total524  Acta Orthopaedica 2011; 82 (5): 521–529
less group 2 operated 1987–1996 was higher than that for the 
cemented THRs operated during the same period (RR = 1.6; 
CI: 1.1-2.3) (p = 0.02) (Table 3, Figure 1).
Survival of THRs for aseptic loosening
In the Cox regression analysis, cementless group 1 had a lower 
risk of revision than the cemented THRs (RR = 0.5; CI: 0.32–
0.74) (p = 0.001) (Table 4 and Figure 2). The 10-year survival 
of cementless group 1 operated 1997–2006 was better than 
that of the same group operated 1987–1996 (Table 4).
Survival of stem groups, aseptic loosening
In the Cox regression analysis, cementless stem group 1 oper-
ated 1987–1996 had a lower risk of revision than the cemented 
Table 3. Survival of THR groups. The endpoint was defined as revision for any reason. 5-, 10-, and 15-year survival rates were obtained from 
the Kaplan-Meier analysis
  A  B  C  D  E  F  G  H  I  J
1987–1996                 
  Cementless modular #1  767  722  95 (94–97)  595  80 (77–83)  108  62 (57–67)  1.30 (0.90–1.88)  0.2
  Cementless modular #2  419  397  97 (95–98)  329  80 (76–83)  78  58 (52–64)  1.56 (1.07–2.27)  0.02
  Cemented THR  140  128  95 (91–99)  105  81 (74–88)  33  71 (62–80)  1.0  –
1997–2006                 
  Cementless modular #1  1,632  775  95 (94–96)  61  79 (62–96)  0  –  1.27 (0.62–2.63)  0.5
  Cementless modular #2  534  334  97 (95–99)  19  –  0  –  0.83 (0.37–1.87)  0.6
  Cemented THR  176  93  96 (93–99)  3  –  0  –  1.0 
Total  3,668               
A  Total hip replacement group
  cementless modular #1: a cementless, straight proximally porous-coated stem and a cementless press-fit porous-coated cup.
  cementless modular #2: a cementless, anatomic proximally porous- and/or hydroxyapatite-coated stem and a press-fit and/or 
  hydroxyapatite-coated cup. 
B  Number of primary operations 
C At risk at 5 years 
D  5-year survival (95% CI) 
E  At risk at 10 years   
F  10-year survival (95% CI) 
G At risk at 15 years   
H 15-year survival (95% CI)   
I  Risk ratio of revision (95% CI) from the Cox regression analysis (other groups were compared with the cemented total hip replacements; 
  adjustment made for age and sex) 
J  p-value
Figure 1. Cox-adjusted survival curves of 3,668 total hip replacements in patients aged less than 55 
years with implant group as the strata factor. The endpoint was defined as revision of the stem and/
or the cup for any reason. Adjustment was made for age and gender. A. THRs performed 1987–1996. 
Cementless group #2 had a significantly worse overall survival than the reference group of cemented 
hip replacements. B. THRs performed 1997–2006. The differences in survival rates between the THR 
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Survival of THRs for any 
reason
The  15-year  survival  for  any 
reason  for  the  cementless  group 
1  operated  on  1987–1996  (62%, 
CI: 57–67) and cementless group 
2  (58%,  CI:  52–66)  operated  on 
during the same time period was 
worse than that of cemented THRs 
(71%,  CI:  62–80),  although  the 
difference  was  not  statistically 
significant (Table 3). The 10-year 
survival  of  cementless  group  1 
operated 1997–2006 was no better 
than that of the same group oper-
ated 1987–1996. In Cox regression 
analysis, there were no statistically 
significant  differences  in  revision 
risk between the groups otherwise, 
but  the  revision  risk  for  cement-Acta Orthopaedica 2011; 82 (5): 521–529 
stem group operated during the same time period (RR = 0.4; 
CI: 0.23–0.68) (p = 0.001) (Table 5 and Figure 2A). The revi-
sion risk of cementless stem group 2 operated 1987–1996 was 
lower than that of the cemented stems operated during the 
same time period (RR = 0.6; CI 0.32–1.00) (p = 0.05) (Table 
5 and Figure 3). 
Survival of cup groups, aseptic loosening
In the Cox regression analysis, the differences in revision rates 
between groups were not statistically significant (Table 6 and 
Figure 4). The 10-year survival of cementless group 1 oper-
ated 1997–2006 was better than that of the same group oper-
ated 1987–1996 (Table 6).
Discussion
We found that the survival of cementless THRs was no differ-
ent from that of cemented THRs in patients under the age of 55 
when revision for any reason served as the endpoint. However, 
excessive wear of the polyethylene liner resulted in numerous 
revisions of modular cementless cups. After 10 years of fol-
low-up, the revision risk in both cementless groups was higher 
than that in the cemented reference group. The data from our 
previous study included years 1980–2001 whereas the current 
study included years 1987–2006. The overall results in the 2 
studies were similar.
This registery-based study has certain limitations. Before 
1994, 10% of total hip replacements were missing from the 
Finnish Arthroplasty Register (Puolakka et al. 2001). These 
total hip replacements that were lost to follow-up could have 
been failures and may have caused bias in our study. It is 
also possible that few centers performed the majority of the 
replacements, and certain complications could have occurred 
more often at certain centers. The number of total hip replace-
ments performed for patients under the less than age of 55 
years of age with osteoarthritis is considerably lower than 
the number of replacements performed for elderly patients 
(Mäkelä  et  al.  2008).  However,  the  number  of  hospitals 
performing  cementless  replacements  for  young  patients  in 
Table 4. Survival of THR groups. The end point was defined as revision due to aseptic loosening of the cup and/or the stem. 5-, 10-, and 
15-year survival rates were obtained from the Kaplan-Meier analysis
  A  B  C  D  E  F  G  H  I  J
1987–1996                 
  Cementless modular #1  767  719  99 (98–99)  589  94 (92–96)  107  82 (77–87)  0.49 (0.32–0.74)  0.001
  Cementless modular #2  419  397  98 (96–99)  325  88 (84–91)  78  70 (64–77)  1.00 (0.66–1.50)  1.0
  Cemented THR  140  128  96 (93–100)  105  82 (76–89)  33  72 (63–81)  1.0  –
1997–2006                 
  Cementless modular #1  1,632  774  99 (98–99)  60  97 (96–98)  0  –  0.69 (0.24–1.99)  0.5
  Cementless modular #2  534  334  99 (98–100)  19  –  0  –  0.68 (0.21–2.23)  0.5
  Cemented THR  176  93  98 (96–100)  3  –  0  –  1.0  –
Total  3,668
A–J See Table 3.  
Table 5. Survival of stem groups. The endpoint was defined as revision due to aseptic loosening of the stem. 5-, 10-, and 15-year survival 
rates were obtained from the Kaplan-Meier analysis
  A  B  C  D  E  F  G  H  I  J
 
1987–1996
  Cementless stem #1  767  717  100 (99–100)  586  97 (96–99)  106  89 (85–93)  0.39 (0.23–0.68)  0.001
  Cementless stem #2  419  396    98 (97–100)  321  95 (93–97)  76  89 (85–93)  0.57 (0.32–1.00)  0.05
  Cemented stem  140  128    96 (93–100)  105  88 (83–100)  33  81 (73–89)  1.0  –
1997–2006                 
  Cementless stem #1  1,632  773    99 (98–100)  60  98 (98–99)  0  –  0.63 (0.18–2.16)  0.5
  Cementless stem #2  534  334    99 (98–100)  19  –  0  –  0.49 (0.12–2.05)  0.3
  Cemented stem  176  93    99 (96–100)  3  –  0  –  1.0  –
Total  3,668               
A  Stem group
  cementless stem # 1: a cementless, straight proximally porous-coated stem. 
  cementless stem # 2: a cementless, anatomic proximally porous- and/or hydroxyapatite-coated stem.
B–H and J See Table 3.   
I  Risk ratio of revision (95% CI) from the Cox regression analysis (other stem groups were compared with the cemented stems; 
  adjustment made for age and sex). 526  Acta Orthopaedica 2011; 82 (5): 521–529
Figure 2. Cox-adjusted survival curves of 3,668 total hip replacements in patients aged less than 
55 years with implant group as the strata factor. The endpoint was defined as revision of the stem 
and/or the cup for aseptic loosening. Adjustment was made for age and gender. A. THRs performed 
1987–1996. Cementless group #1 had a significantly better overall survival than the reference group 
of cemented THRs. B. THRs performed 1997–2006. The differences in survival rates between the 
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Figure 3. Cox-adjusted survival curves of 3,668 stems in patients aged less than 55 years with stem 
group as the strata factor. The endpoint was defined as stem revision due to aseptic loosening. 
Adjustment was made for age and sex. A. THRs performed 1987–1996. Cementless stem group 1 
had a significantly better overall survival than the reference group of cemented stems. B. THRs per- THRs per-
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the current study was high. The total number of cemented 
implants was low. The data ofn cement brands used have been 
included in the Finnish Register since 1996. We excluded 
cement brands with known poor results, such as Boneloc and 
CMW, from the study to eliminate the effect of cement on 
the survival of cemented implants. This further reduced the 
number of cemented THRs. The cement brands were used in 
1987–1995 are not known. 
found that the risk of revision is indeed higher in younger 
patients  than  in  older  ones  (Herberts  and  Malchau  2000, 
Furnes et al. 2001). A good 10-year survival rate of ≥ 90% 
(NICE) has been recorded for some cementless THAs within 
patients underbelow 55 years of age, although many of these 
reports have been from highly specialized clinics and refer to 
only one brand of implant (Kim et al. 2002, 2003, McAuley et 
al. 2004, Pieringer et al. 2006, Delaunay et al. 2008, Reigstad 
A  limitation  of  most  register-
based  studies  is  that  only  a  revi-
sion  operation  is  considered  as  a 
definition  of  failure.  There  might 
be patients with polyethylene fail-
ure  and  osteolysis  who  are  not 
even aware of the problem. In this 
respect, however, younger patients 
are probably better off than elderly 
patients,  who  might  be  too  ill  to 
undergo  revision  surgery  or  who 
simply  prefer  not  to  do  so.  It  is 
more common to perform revision 
surgery  when  needed  for  younger 
patients with a long lifetime expec-
tation than for elderly patients. In 
this  respect,  a  revision  operation 
may be considered as a reasonable 
definition  of  failure  in  a  register-
based study for patients under the 
age of 55 years.
Porous-coated  cementless  cups 
implanted during the period 1997–
2006  had  better  10-year  survival 
regarding  aseptic  loosening  than 
those implanted during 1987–1996. 
However, 10-year survival for any 
reason of the later cohort of cement-
less group 1 was no better than that 
of  the  earlier  cohort  of  the  same 
group.  This  finding  is  worrisome, 
because  it  seems  that  although 
cementless cups heal well with bony 
ingrowth, modern liner options have 
not  provided  anything  new  com-
pared  to  the  older  ones  regarding 
the problem of wear and osteolysis. 
However, the number of implants at 
risk in 10 years in the later cohort 
was small compared to the earlier 
one. 
The main concern of patients with 
long life expectancy and of patients 
who  are  younger  and  more  active 
is  the  longevity  of  their  total  hip 
arthroplasty. Previous studies have Acta Orthopaedica 2011; 82 (5): 521–529 
et al. 2008, Garcia-Rey et al. 2009, Anseth et al. 2010). Excel-
lent survival results have also been reported using cemented 
implants for  young, high-demand patients with higher physi-
cal demands (SHAR 2007, Lewthwaite et al. 2008).
In  the  present  study,  survival  of  cementless  stems  with 
aseptic  loosening  as  the  end  point  was  superior  to  that  of 
cemented stems in patients under the age of 55 years. How-
ever, the large number of wear-related revisions emphasizes 
the  need  for  more  wear-resistant  articulations  for  cement-
less cups. For a single patient, each reoperation—including 
exchange of liner—is a major incident. Therefore, revisions 
for all reasons should be emphasized in survival analyses. 
Although there have been reports of the complications associ-
hip arthroplasty appeared to be relatively unsatisfactory for 
younger patients in Finland.
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Figure 4. Cox-adjusted survival curves of 3,668 cups in patients aged less than 55 years with cup 
group as the strata factor. The end point was defined as cup revision due to aseptic loosening. Adjust-
ment was made for age and sex. A. THRs performed 1987–1996. The differences in survival rates 
between the cup groups were not statistically significant. B. THRs performed 1997–2006. The differ- THRs performed 1997–2006. The differ- The differ-
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Table 6. Survival of cup groups. The endpoint was defined as revision due to aseptic loosening of the cup. 5-, 10-, and 15-year survival rates 
were obtained from the Kaplan-Meier analysis
  A  B  C  D  E  F  G  H  I  J
1987–1996                 
  Cementless cup #1  1,075  1,010    99 (98–99)  831  92 (91–94)  183  79 (75–82)  0.79 (0.52–1.22)  0.3
  Cementless cup #2  111  105  100 (100–100)  82  94 (88–99)  2  –  0.69 (0.32–1.50)  0.4
  Cemented cup  140  127    97 (94–100)  105  86 (80–93)  33  76 (68–85)  1.0  –
1997–2006                 
  Cementless cup #1  1,512  723    99 (99–100)  58  98 (97–99)  0  –  0.40 (0.13–1.25)  0.1
  Cementless cup #2  654  385  100 (99–100)  20  96 (92–99)  0  –  0.45 (0.13–1.54)  0.2
  Cemented cup  176  93    98 (96–100)  3  –  0  –  1.0  –
Total  3,668               
A  Cup group
  cementless cup # 1: a cementless, press-fit porous-coated cup.
  cementless cup # 2: a cementless hydroxyapatite-coated cup.
B–H and J See Table 3.
I  Risk ratio of revision (95% CI) from the Cox regression analysis (other cup groups were compared with the all-polyethylene cemented cups; 
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Appendix. Implant brands and bone cements used
  A  B  C  D  E  F  G  H 
Biomet Bimetric  ABG I  Biomet PFU  ABG I  ABG I  Lubinus IP  Lubinus Std  Palacos C Genta
Synergy  ABG II  Biomet Vision  ABG II  ABG II  Lubinus SP I  Müller Std  Simplex Antib
Profile porous  Anatomic Mesh  Harris-Galante II  PCA Pegged  Omnifit Trident  Lubinus SP II  Exeter All-poly  Simplex P
Bicontact  PCA Std  Biomet 38  PCA Vitalock    Exeter Universal  Exeter Contemporary  Palacos R+G
Biomet Integral Lat  PCA E-eries  Biomet M2A  PCA cluster    Müller Monolog    Charnley LPW  Simplex
Biomet Head-Neck  PCA Meridian  Biomet Recap  Omnifit Trident    Charnley  Brunswik  Simplex/Palacos
Proxiloc    Biomet Mallory      Brunswik  Lubinus Eccentric  Palacos
       Trilogy      Spectron  Reflection All-poly  Palacos R Genta
    Biomex          Simplex
    Pinnacle          Tobramy
    Profile Duraloc         
    Bicontact         
    BHR         
    Hedrocel         
    ASR
         
A  Cementless stems #1 
B  Cementless stems #2 
C Cementless cups #1 
D Cementless cups #2 
E  HA-coated cups 
F  Cemented stems 
G Cemented cups 
H Bone cements